肺肿瘤核素显像的临床应用进展

邓智勇 杨丽春

引用本文:
Citation:

肺肿瘤核素显像的临床应用进展

Clinical advance in radionuclide imaging of pulmonary cancer

  • 摘要: 核素显像在肺癌的诊断、分期、治疗后复发转移的监测、疗效和预后的判断等方面展示了重要的临床价值,日益受到临床的重视。对临床较为常用的67Ga、201Tl、99Tcm18F等放射性核素及其标记化合物的显像原理、临床应用、优缺点及进展情况进行介绍,并重点介绍了99Tcm甲氧基异丁基异腈(99Tcm-MIBI)、99Tcm-HL91、18F-氟脱氧葡萄糖(18F-FDG)肺肿瘤核素显像的l临床应用进展。
  • [1] Bombardieri E,Aktolun C,Baum RP,et al.67Ga scintigraphy:procedure guidelines for tumor imaging[J].Eur J Nucl Med Mol Imaging,2003,30(12):125-131.
    [2] Momose M,Sone S,Maruyama Y,et al.Performance of degree of accumulation with 201T1-SPECT in 13 cases of lung cancer smaller than 2 cm[J].Nippon Igaku Hoshasen Gakkai Zasshi,2000,60(12):699-701.
    [3] Nosotti M,Santambrogio L,Gasparini M,et al.Role of 99nfTchexakis-2-methoxy-isobutylisonitrile in the diagnosis and staging of lung cancer[J].Chest,2002,122(4):1361-1364.
    [4] Furuta M,Nozaki M,Kawashima M,et al.99nfTc-MIBI seintigraphy for early detection of locally recurrent non-small cell lung cancer treated with definitive radiation therapy[J].Eur J Nucl Med Mol Imaging,2003,30(7):982-987.
    [5] 黄建敏,曲雁,潘莉萍.恶性骨肿瘤多药耐药的99mTc-MIBI体层显像研究[J].国外医学:放射医学核医学分册,2005,29(4):169-170.
    [6] Kinuya S,Bai J,Shiba K,et al.99mTc-sestamibi to monitor treatment with antisense oligodeoxynucleotide complementary to MRP mRNA in human breast cancer cells[J].Ann of Nucl Med,2006,20(1):29-34.
    [7] Akgun A,Cok G,Karapolat I,et al.Tc-99mMIBI SPECT in prediction of prognosis in patients with small cell lung cancer[J].Ann of Nucl Med,2006,20(4):269-275.
    [8] Yuksel M,Cermik TF,Doganay L,et al.99mTc-MIBI SPECT in nonsmall cell lung cancer in relationship with Pgp and prognosis[J].Eur J Nucl Med Mol Imaging,2002,29(7):876-881.
    [9] 陈刚,王荣福.核医学肿瘤乏氧显像的进展[J].北京大学学报:医学版,2006,38(3):335-336.
    [10] Imahashi K,Morishita K,Kusuoka H,et al.Kinetics of a putative hypoxic tracer 99mTc-HL91,in nonmoxic,hypoxic,ischemic,and stunned myocardiurn[J]J Nuel Med,2000,41(6):1102-1107.
    [11] 邓波,肖欢,陈小凤,等.核素乏氧显像和亲肿瘤显像及CT检查诊断肺癌的对比研究[J].中国医师杂志,2005,7(12):1641-1642.
    [12] Suzuki T,Nakamura K,Kawase T,et al.Monitoring of response to radiation therapy for human tumor xenografts using 99mTc-HL91(4,9-diaza-3,3,10,10-tetramethyldodeean-2,11-dione dioxime)[J].Ann Nuel Med,2003,17(2):131-138.
    [13] Li L,Yu J,Xing L,et al.Serial hypoxia imaging with 99mTc-HL91 SPECT to predict radiotherapy response in non small cell lung cancer[J].Am J Clin Oncol,2006,29(6):628-633.
    [14] Coerres GW,Kamel E,Seifert B,et al.Accuracy of image coregistration of pulmonary lesions in patients with non-small cell lung cancer using an integrated PET/CT system[J].J Nucl Med,2002,43(11):1469-1475.
    [15] Lardinois D,Weder W,Hany TF,et al.Staging of non-small-cell lung cancer with integrated positron emission tomography and computed tomography[J].N Engl J Med,2003,348(25):2500-2507.
    [16] Hany TF,Steinert HC,Goerres GW,et al.PET diagnostic accuracy:improvement with in-line PET-CT system:initial resuhs[J].Radiology,2002,225(2):575-581.
    [17] Antoeh G,Stattaus J,Nemat AT,et al.Non-small cell lung cancer:dual-modality PET/CT in preoterative staging[J].Radiology,2003,229(2):526-533.
    [18] Keidar Z,Haim N,Guralnik L,et al.PET/CT using 18F-FDG in suspected lung cancer recurrence:diagnostic value and impact on patient management[J].J Nucl Med,2004,45(10):1640-1646.
    [19] Nahmias C,Hanna WT,Wahl LM,et al.Time course of early response to chemotherapy in non-small cell lung cancer patients with 18F-FDG PET/CT[J].J Nucl Med,2007,48(5):744-751.
    [20] Blum J,Handmaker H,Lister-James J,et al.A multicenter trial with a somatostatin analog (99m) Tc depreotide in the evaluation of solitary pulmonary nodules[J].Chest,2000,117(5):1232-1238.
    [21] Bradley J,Thorstad WL,Mutic S,et al.Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer[J].Int Radiat Oncol Biol Phys,2004,59(1):78-86.
  • [1] 谭兴普黄艳99Tcm-MIBI亲肿瘤延迟断层显像对肺占位病灶的诊断价值. 国际放射医学核医学杂志, 2010, 34(5): 297-299. doi: 10.3760/cma.j.issn.1673-4114.2010.05.012
    [2] 杨爱民于燕邓惠兴李杰99Tcm-HL91和18F-FDG显像与放疗关系的实验研究. 国际放射医学核医学杂志, 2011, 35(4): 217-219, 248. doi: 10.3760/cma.j.issn.1673-4114.2011.04.005
    [3] 胡旻刘雅洁许小飞盛丹丹王颖99Tcm-MIBI动态血流灌注显像和双时相核素显像对甲状腺冷结节良恶性的诊断价值研究. 国际放射医学核医学杂志, 2010, 34(3): 174-176. doi: 10.3760/cma.j.issn.1673-4114.2010.03.013
    [4] 成钊汀陈璟朱小华 . 甲状旁腺癌双肺多发转移99Tcm-MIBI SPECT/CT显像一例. 国际放射医学核医学杂志, 2017, 41(4): 303-304. doi: 10.3760/cma.j.issn.1673-4114.2017.04.013
    [5] 龙再颖曲新艳单英丽99Tcm-MIBI显像对甲状腺结节良恶性鉴别诊断价值的研究. 国际放射医学核医学杂志, 2010, 34(2): 80-83. doi: 10.3760/cma.j.issn.1673-4114.2010.02.004
    [6] 吴娇娇严颖卫华 . 放射性核素显像在甲状旁腺功能亢进症诊断中的研究进展. 国际放射医学核医学杂志, 2023, 47(8): 503-508. doi: 10.3760/cma.j.cn121381-202211001-00326
    [7] 苏新辉吴华99mTc-HL91乏氧显像探测肿瘤乏氧状态的研究进展. 国际放射医学核医学杂志, 2006, 30(4): 220-222.
    [8] 郭睿晋建华99mTc-depreotide生长抑素受体显像的临床应用研究. 国际放射医学核医学杂志, 2007, 31(3): 154-157.
    [9] 侯仁花吕中伟 . 生长抑素受体显像剂99mTc-depreotide的研究进展. 国际放射医学核医学杂志, 2008, 32(1): 15-18.
    [10] 张金山吴兆红邓咏梅李敏林炎彬黄桂敏99mTc-MIBI联合99mTc-HL91乏氧显像对60例原发性肺癌的诊断评价. 国际放射医学核医学杂志, 2006, 30(5): 287-289.
  • 加载中
计量
  • 文章访问数:  1506
  • HTML全文浏览量:  118
  • PDF下载量:  3
出版历程
  • 收稿日期:  2008-02-26

肺肿瘤核素显像的临床应用进展

  • 650118 昆明, 云南省肿瘤医院PET-CT中心

摘要: 核素显像在肺癌的诊断、分期、治疗后复发转移的监测、疗效和预后的判断等方面展示了重要的临床价值,日益受到临床的重视。对临床较为常用的67Ga、201Tl、99Tcm18F等放射性核素及其标记化合物的显像原理、临床应用、优缺点及进展情况进行介绍,并重点介绍了99Tcm甲氧基异丁基异腈(99Tcm-MIBI)、99Tcm-HL91、18F-氟脱氧葡萄糖(18F-FDG)肺肿瘤核素显像的l临床应用进展。

English Abstract

参考文献 (21)

目录

    /

    返回文章
    返回